Apr. 23, 2013 ? Researchers at Micro Orthopaedics, Zhongnan Hospital of Wuhan University, led by Dr. Ai-xi Yu, have suggested that articular cartilage defects can be repaired by a novel thermo-sensitive injectable hydrogel engineered with gene modified bone marrow mesenchymal stromal cells (BMSCs). The chitosan and polyvinyl alcohol composite hydrogel containing hTGF?-1 gene modified BMSCs was injected into rabbits with defective articular cartilage. Sixteen weeks later the defected cartilage regenerated and was proven to be hyaline cartilage.
This work can be found in the January 2013 issue of Experimental Biology and Medicine.
"No reliable approach is currently available for complete restoration of damaged articular cartilage," said Dr. Bai-wen Qi, "in this study, CS/PVA gel was combined with rabbit bone marrow stromal cells (BMSCs) transfected with hTGF?-1 and used to repair rabbit articular cartilage defects and the repair effect was evaluated."
Tissue engineering combined with gene therapy technology has the potential to manage the repair of defective articular cartilage. In this study, through minimally invasive injection methods the authors were able to repair rabbit articular cartilage defects with CS/PVA gel and gene modified BMSCs. Dr. Qi said "CS/PVA gel can be applied to the repair of articular cartilage defects as an injectable material in tissue engineering, and the regenerated cartilage can secrete cartilage matrix and perform the functions of hyaline cartilage. Use of this gel for cartilage repair has advantages such as the minor surgical procedure required, tight bonding with the damaged tissue and lack of rejection."
Dr. Steven R. Goodman, Editor-in-Chief of Experimental Biology and Medicine said "The study by Qi and colleagues is very exciting as it combines tissue engineering and gene therapy approaches to successfully repair defective articular cartilage. The approach should be adaptable in the future to human tissue repair."
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by Society for Experimental Biology and Medicine, via EurekAlert!, a service of AAAS.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- B.-w. Qi, A.-x. Yu, S.-b. Zhu, M. Zhou, G. Wu. Chitosan/poly(vinyl alcohol) hydrogel combined with Ad-hTGF-?1 transfected mesenchymal stem cells to repair rabbit articular cartilage defects. Experimental Biology and Medicine, 2013; 238 (1): 23 DOI: 10.1258/ebm.2012.012223
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/~3/ECzWDwvlCpc/130423144307.htm
evo 4g lte marlins new stadium arnold palmer augusta national blake griffin pau gasol marlins park
In late March, the American Geophysical Union announced that the Voyager I space probe became the first man-made object to leave our solar system. Just a few hours later though, NASA's Jet Propulsion Laboratory shot down that claim noting that the tell-tale sign of hitting interstellar space (a "change in the direction of the magnetic field") hasn't been detected yet. Still, this whole thing got me thinking: NASA launched Voyager I in 1972 to peer more closely at the outer planets. By late 1980, the probe had completed its tour of Jupiter and Saturn and made a gravity-assisted beeline for the edge of the solar system. In the 40 or so years that Voyager has toured the outer fringes of the solar system, our focus on space has grown more limited, and in many ways it's a new breed of space-based startups that are helping to spark imaginations the way NASA has done for decades.